142 related articles for article (PubMed ID: 24014886)
1. Chemically induced pluripotent stem cells (CiPSCs): a transgene-free approach.
Masuda S; Wu J; Hishida T; Pandian GN; Sugiyama H; Izpisua Belmonte JC
J Mol Cell Biol; 2013 Oct; 5(5):354-5. PubMed ID: 24014886
[TBL] [Abstract][Full Text] [Related]
2. Brief report: combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts.
Yuan X; Wan H; Zhao X; Zhu S; Zhou Q; Ding S
Stem Cells; 2011 Mar; 29(3):549-53. PubMed ID: 21425417
[TBL] [Abstract][Full Text] [Related]
3. Two-step generation of induced pluripotent stem cells from mouse fibroblasts using Id3 and Oct4.
Moon JH; Heo JS; Kwon S; Kim J; Hwang J; Kang PJ; Kim A; Kim HO; Whang KY; Yoon BS; You S
J Mol Cell Biol; 2012 Feb; 4(1):59-62. PubMed ID: 22131360
[No Abstract] [Full Text] [Related]
4. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of somatic cells after fusion with induced pluripotent stem cells and nuclear transfer embryonic stem cells.
Sumer H; Jones KL; Liu J; Heffernan C; Tat PA; Upton KR; Verma PJ
Stem Cells Dev; 2010 Feb; 19(2):239-46. PubMed ID: 19637940
[TBL] [Abstract][Full Text] [Related]
6. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
[TBL] [Abstract][Full Text] [Related]
7. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.
Desponts C; Ding S
Methods Mol Biol; 2010; 636():207-18. PubMed ID: 20336525
[TBL] [Abstract][Full Text] [Related]
8. Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.
Varga E; Nemes C; Davis RP; Ujhelly O; Klincumhom N; Polgar Z; Muenthaisong S; Pirity MK; Dinnyes A
Exp Cell Res; 2014 Apr; 322(2):335-44. PubMed ID: 24560743
[TBL] [Abstract][Full Text] [Related]
9. Global transcriptional analysis of nuclear reprogramming in the transition from MEFs to iPSCs.
Dong F; Song Z; Zhang J; Lu Y; Song C; Jiang B; Zhang B; Cong P; Sun H; Shi F; Liu H
Genes Cells; 2013 Jan; 18(1):42-55. PubMed ID: 23231677
[TBL] [Abstract][Full Text] [Related]
10. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
[TBL] [Abstract][Full Text] [Related]
11. Exploring refined conditions for reprogramming cells by recombinant Oct4 protein.
Thier M; Münst B; Edenhofer F
Int J Dev Biol; 2010; 54(11-12):1713-21. PubMed ID: 21404191
[TBL] [Abstract][Full Text] [Related]
12. Concise review: Oct4 and more: the reprogramming expressway.
Sterneckert J; Höing S; Schöler HR
Stem Cells; 2012 Jan; 30(1):15-21. PubMed ID: 22009686
[TBL] [Abstract][Full Text] [Related]
13. Stem-cell progress.
Callaway E
Nature; 2010 Dec; 468(7325):746. PubMed ID: 21150968
[No Abstract] [Full Text] [Related]
14. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a reporter system to monitor silencing status in induced pluripotent stem cell lines.
Donai K; Kuroda K; Guo Y; So KH; Sone H; Kobayashi M; Nishimori K; Fukuda T
Anal Biochem; 2013 Dec; 443(1):104-12. PubMed ID: 23973628
[TBL] [Abstract][Full Text] [Related]
16. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.
Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J
Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235
[TBL] [Abstract][Full Text] [Related]
17. Enhancing somatic nuclear reprogramming by Oct4 gain-of-function in cloned mouse embryos.
Pfeiffer MJ; Balbach ST; Esteves TC; Crosetto N; Boiani M
Int J Dev Biol; 2010; 54(11-12):1649-57. PubMed ID: 21136379
[TBL] [Abstract][Full Text] [Related]
18. Intrachromosomal looping is required for activation of endogenous pluripotency genes during reprogramming.
Zhang H; Jiao W; Sun L; Fan J; Chen M; Wang H; Xu X; Shen A; Li T; Niu B; Ge S; Li W; Cui J; Wang G; Sun J; Fan X; Hu X; Mrsny RJ; Hoffman AR; Hu JF
Cell Stem Cell; 2013 Jul; 13(1):30-5. PubMed ID: 23747202
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cells.
Deyle DR
Methods Mol Biol; 2015; 1226():43-58. PubMed ID: 25331042
[TBL] [Abstract][Full Text] [Related]
20. Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells.
Tsai SY; Bouwman BA; Ang YS; Kim SJ; Lee DF; Lemischka IR; Rendl M
Stem Cells; 2011 Jun; 29(6):964-71. PubMed ID: 21563278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
